Hodgkin lymphoma at the paediatric oncology unit of gabriel touré teaching hospital, bamako, mali: 5-year experience [0.03%]
马里巴马科加布里埃尔·图雷教学医院儿科肿瘤科5年霍奇金淋巴瘤治疗经验
B Togo,F Traoré,A P Togo et al.
B Togo et al.
Introduction. The aim of this retrospective, unicentric study over 5 years is to describe the epidemiologic, pathologic, clinic and therapeutic aspects of children treated for Hodgkin lymphoma in our paediatric oncology unit. Patients and M...
Pier Paolo Piccaluga,Anna Gazzola,Claudia Mannu et al.
Pier Paolo Piccaluga et al.
The authors revise the concept of anaplastic large cell lymphoma (ALCL) in the light of the recently updated WHO classification of Tumors of Hematopoietic and Lymphoid Tissues both on biological and clinical grounds. The main histological f...
Human Immunodeficiency Virus Infection and Hodgkin's Lymphoma in South Africa: An Emerging Problem [0.03%]
南非人类免疫缺陷病毒与霍奇金淋巴瘤：一个日益严重的问题
Moosa Patel,Vinitha Philip,Fatima Fazel
Moosa Patel
Hodgkin's lymphoma (HL) occurs with increasing frequency in human-immunodeficiency-virus-(HIV-) infected individuals. The natural history and behaviour of HIV-HL is different, being more atypical and aggressive. The association between HIV ...
Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies [0.03%]
霍奇金淋巴瘤发病机制的最新进展及其对诊断、预后和治疗策略的影响
Diponkar Banerjee
Diponkar Banerjee
From its first description by Thomas Hodgkin in 1832, Hodgkin's disease, now called Hodgkin's lymphoma, has continued to be a fascinating neoplasm even to this day. In this review, historical aspects, epidemiology, diagnosis, tumor biology,...
Prognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography [0.03%]
霍奇金淋巴瘤的预后及符合病情的治疗(采用正电子发射体层摄影)
Yvette L Kasamon
Yvette L Kasamon
The use of (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) for response assessment in lymphoma is now widespread. Prognostic information obtained from PET performed after two to three cycles of chemotherapy may guide more in...
Pier Paolo Piccaluga,Claudio Agostinelli,Anna Gazzola et al.
Pier Paolo Piccaluga et al.
Despite its well-known histological and clinical features, Hodgkin's lymphoma (HL) has recently been the object of intense research activity, leading to a better understanding of its phenotype, molecular characteristics, histogenesis, and p...
Impact of autologous and allogeneic stem cell transplantation in peripheral T-cell lymphomas [0.03%]
自体和异基因干细胞移植在外周T细胞淋巴瘤中的作用
Peter Reimer
Peter Reimer
Peripheral T/NK-cell lymphomas (PTCLs) are rare malignancies characterized by poor prognosis. So far, no standard therapy has been established, due to the lack of randomised studies. High-dose therapy and autologous stem cell transplantatio...
Francesco Gaudio,Annamaria Giordano,Vincenzo Pavone et al.
Francesco Gaudio et al.
Recurrences of Hodgkin's Lymphoma (HL) 5 years after the initial therapy are rare. The aim of this study is to report a single centre experience of the clinical characteristics, outcome, and toxicity of pts who experienced very late relapse...
PET Response-Guided Treatment of Hodgkin's Lymphoma: A Review of the Evidence and Active Clinical Trials [0.03%]
霍奇金淋巴瘤的功能性影像指导个体化治疗：证据及临床试验现状综述
Paul Aridgides,Jeffrey Bogart,Anna Shapiro et al.
Paul Aridgides et al.
Risk-adaptive therapy for Hodgkin's lymphoma focuses on treatment modifications based on assessment of response. [(18)F]Fluoro-deoxyglucose positron emission tomography (PET) performed during or after completion of chemotherapy is a strong ...
Peripheral T-cell lymphoma: review and updates of current management strategies [0.03%]
外周T细胞淋巴瘤：当前治疗策略的回顾与更新
Tiffany Tang,Kevin Tay,Richard Quek et al.
Tiffany Tang et al.
The classification of T-cell and natural-killer- (NK-) cell lymphomas has been updated in the 4th edition of the World Health Organization (WHO) classification of tumors of the haematopoietic and lymphoid tissue published in 2008. Based on ...